No Data
No Data
Notable Earnings Before Tuesday's Open
Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024
PDF VersionLONDON, July 16, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 2
The 13% Return This Week Takes Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) Shareholders Three-year Gains to 60%
Express News | Kiniksa Pharmaceuticals Commences Enrollment In Its Abiprubart Phase 2b Clinical Trial In Sjögren's Disease
Express News | Kiniksa Pharmaceuticals Ltd - Expects to Remain Cash Flow Positive Annually
Express News | Kiniksa Pharmaceuticals Ltd - Abiprubart Trial in Sjögren's Disease Fully Funded
No Data